We believe investors should be turning their attention to tackling global biodiversity loss. Global biodiversity loss is estimated to be 100 to 1,000 times higher than the (naturally occurring) background extinction rate, faster than at any other time in human history (or, indeed, in the last 66 million years).1 This loss is already affecting food security, livelihoods, health and quality of life worldwide, and in economic terms, more than half of the world’s GDP is at moderate to severe risk.2 This article aims to provide a high-level introduction to biodiversity for investors; we will continue our work in this space and further develop our thinking both as we research asset managers and meeting client demand.
 

Apart from an absolute moral obligation to conserve nature, recognized by secular ethicists3 and religious creeds alike, humanity’s prospects are indelibly tied to it. We know, for example, that human well-being is linked to green space,4 that the human body is entirely dependent on bacteria and other microbes (approximately half of the cells in our bodies are nonhuman)5 that the human body is entirely dependent on photosynthesizing species for oxygen, and that the human body relies almost exclusively on organic matter for nourishment. Moreover, not only are we dependent on natural foodstuffs, but these foodstuffs also rely on a wide array of species: pollinators, such as insects, and organisms in the soil, such as bacteria, earthworms and mycorrhizal fungi.

I would like to speak to a Mercer consultant

 

1 See Wikipedia Biodiversity Loss (11/5/21) at https://en.wikipedia.org/wiki/Biodiversity_loss.

2 Business for Nature Coalition, 2021, available at https://www.businessfornature.org/.

3 For further reading, see Taylor PW. “The Ethics of Respect for Nature,” Environmental Ethics, Volume 3, Issue 3 (1981), pp. 197–218.

4 Houlden V, Weich S, de Albuquerque JP, Jarvis S, Rees K. “The Relationship Between Greenspace and the Mental Wellbeing of Adults: A Systematic Review,” PLOS One, Volume 13, Issue 9 (2018).

5 Sender R, Fuchs S, Milo R. “Revised Estimates for the Number of Human and Bacteria Cells in the Body,” PLOS Biology , Volume 14, Issue 8 (2016).

  • Important notices

    References to Mercer shall be construed to include Mercer LLC and/or its associated companies.

    © 2021 Mercer LLC. All rights reserved.

    References to Mercer shall be construed to include Mercer LLC and/or its associated companies.

    This contains confidential and proprietary information of Mercer and is intended for the exclusive use of the parties to whom it was provided by Mercer. Its content may not be modified, sold or otherwise provided, in whole or in part, to any other person or entity without Mercer’s prior written permission.

    This does not constitute an offer to purchase or sell any securities.

    The findings, ratings and/or opinions expressed herein are the intellectual property of Mercer and are subject to change without notice. They are not intended to convey any guarantees as to the future performance of the investment products, asset classes or capital markets discussed.

    Past performance does not guarantee future results. Mercer’s ratings do not constitute individualized investment advice. The value of investments can go down as well as up, and you may not get back the amount you have invested. Investments denominated in a foreign currency will fluctuate with the value of the currency. Certain investments, such as securities issued by small capitalization, foreign and emerging market issuers, real property, and illiquid, leveraged or high-yield funds, carry additional risks that should be considered before choosing an investment manager or making an investment decision.

    This does not contain investment advice relating to your particular circumstances. No investment decision should be made based on this information without first obtaining appropriate professional advice and considering your circumstances. Mercer provides recommendations based on the particular client’s circumstances, investment objectives and needs. As such, investment results will vary and actual results may differ materially.

    For Mercer’s conflict of interest disclosures, contact your Mercer representative or see http://www.mercer.com/conflictsofinterest.

    Information contained herein has been obtained from a range of third-party sources. Although the information is believed to be reliable, Mercer has not sought to verify it independently. As such, Mercer makes no representations or warranties as to the accuracy of the information presented and takes no responsibility or liability (including for indirect, consequential or incidental damages) for any error, omission or inaccuracy in the data supplied by any third party.

    Mercer does not provide tax or legal advice. You should contact your tax advisor, accountant and/or attorney before making any decisions with tax or legal implications.

    Not all services mentioned are available in all jurisdictions. Please contact your Mercer representative for more information.

    Investment management and advisory services for US clients are provided by Mercer Investments LLC (Mercer Investments). Mercer Investments LLC is registered to do business a  s “Mercer Investment Advisers LLC” in the following states: Arizona, California, Florida, Illinois, Kentucky, New Jersey, North Carolina, Oklahoma, Pennsylvania, Texas and West Virginia; as “Mercer Investments LLC (Delaware)” in Georgia; as “Mercer Investments LLC of Delaware” in Louisiana; and “Mercer Investments LLC, a limited liability company of Delaware” in Oregon. Mercer Investments is a federally registered investment adviser under the Investment Advisers Act of 1940, as amended. Registration as an investment adviser does not imply a certain level of skill or training. The oral and written communications of an adviser provide you with information about which you determine to hire or retain an adviser. Mercer Investments’ Form ADV Parts 2A and 2B can be obtained by written request directed to: Compliance Department, Mercer Investments, 99 High Street, Boston, MA 02110.

    Certain regulated services in Europe are provided by Mercer Global Investments Europe Limited and Mercer Limited. Mercer Global Investments Europe Limited and Mercer Limited are regulated by the Central Bank of Ireland under the European Union (Markets in Financial Instruments) Regulation 2017, as an investment firm. Registered officer: Charlotte House, Charlemont Street, Dublin 2, Ireland. Registered in Ireland No. 416688. Mercer Limited is authorized and regulated by the Financial Conduct Authority. Registered in England and Wales No. 984275. Registered Office: 1 Tower Place West, Tower Place, London EC3R 5BU.

    Investment management services for Canadian investors are provided by Mercer Global Investments Canada Limited. Investment consulting services for Canadian investors are provided by Mercer (Canada) Limited.

    July 2021